Results 131 to 140 of about 60,209 (283)
Drug target prediction algorithms based on proteogenomic profiling. Abstract Background The utilization of PD1 and CTLA4 inhibitors has revolutionized the treatment of malignant melanoma (MM). However, resistance to targeted and immune‐checkpoint‐based therapies still poses a significant problem.
Indira Pla+35 more
wiley +1 more source
Introduction. Sirolimus has inhibitory effects on epithelial healing and cholangiocyte regeneration. In liver transplantation (LT) patients, these effects may be greatest at the biliary anastomosis.
James H. Tabibian, M.D.+8 more
doaj
ABSTRACT Background BK Polyoma virus (BKV) can lead to significant renal complications in immunocompromised individuals. While commonly observed in kidney transplant recipients, its occurrence in non‐renal solid organ transplant (NRSOT) recipients remains rare.
Kann Rachel+5 more
wiley +1 more source
Acquired Genotype‐Positive Long QT Syndrome After Pediatric Heart Transplantation
ABSTRACT Background Congenital long QT syndrome (LQTS) is rare but significant, as it carries a risk for ventricular arrhythmias and sudden cardiac death. Its diagnosis can be made clinically by serial ECGs, ambulatory ECG monitoring, and exercise stress testing; however, genetic testing is confirmatory in the majority of cases.
Nicholas V. Barresi+3 more
wiley +1 more source
Validation of an Assay for Routine Monitoring of Sirolimus Using HPLC with Mass Spectrometric Detection [PDF]
David W. Holt+3 more
openalex +1 more source
Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease [PDF]
Background. We initiated a randomized controlled clinical trial to assess the effect of sirolimus on disease progression in patients affected by autosomal dominant polycystic kidney disease (ADPKD).
Kistler, Andreas D.+10 more
core
The modified residual functional SYNTAX score (m‐rFSS) algorithm was updated for 2 clinical scenarios: 1) lesions with suboptimal functional results, and 2) angiographic diameter stenosis <50% but functionally significant stenoses, which were not scored by classic rFSS or rSS.
Rui Zhang+15 more
wiley +1 more source
ABSTRACT Background Biodegradable polymer stents may reduce the risk of neoatherosclerosis and stent thrombosis. Limited data is available for biodegradable polymer sirolimus‐eluting stent (BP‐SES) and durable polymer drug‐eluting stents (DP‐EES) in chronic total occlusions (CTO).
Geng Wang+8 more
wiley +1 more source
An unusual cause of cancer mimicry following liver transplantation
Sirolimus is an approved anti-rejection agent following liver or kidney transplantation that works through inhibition of the mammalian target of rapamycin (mTOR). As sirolimus functions through a pathway independent of calcineurin inhibition, it may have
Karim Qumosani, Natasha Chandok
doaj
ABSTRACT Introduction Artemis (DCLRE1C) deficiency causes radiosensitive severe combined immunodeficiency (SCID), although hypomorphic cases can manifest later‐onset immunodeficiency, autoimmunity, or lymphoproliferation. We report a 45‐year‐old man with humoral immunodeficiency, opportunistic infections, and recurrent EBV‐positive diffuse large B‐cell
Lucie Roussel+9 more
wiley +1 more source